Hematologic Changes in Pregnancy

Chapter 67 Hematologic Changes in Pregnancy



Caroline Cromwell



Table 67-1 Initiation of Treatment in Pregnant Patients With Idiopathic Thrombocytopenic Purpura















Platelet Count Treatment
<10,000/µL Platelet transfusion for life-threatening bleeding
10,000-30,000/µL Consider monitoring in first trimester; treat in second or third trimester
>30,000/µL Clinically monitor

image

Figure 67-1 MICROANGIOPATHIC HEMOLYTIC ANEMIA.


Microangiopathic hemolytic anemia in pregnancy, peripheral blood smear (A and B). Evidence of microangiopathy with the formation of schistocytes, fragmented forms and spherocytes, associated with polychromasia and nucleated red blood cells (A and B, detail).



Imatinib Therapy


A 38-year-old woman with a history of chronic phase CML on imatinib therapy for 5 years becomes pregnant. She has had a complete cytogenetic response. She asks what to do about her imatinib therapy.

Related posts:

Heme Biosynthesis and Its Disorders: Sideroblastic Anemia Infectious Mononucleosis and Other Epstein-Barr Virus–Associated Diseases: Part 2 Thrombotic Thrombocytopenic Purpura and the Hemolytic Uremic Syndrome Hematology in Aging Disorders of Phagocyte Function Inherited Forms of Bone Marrow Failure

Stay updated, free articles. Join our Telegram channel
Tags:
Jun 12, 2016 | Posted by in HEMATOLOGY | Comments Off on Hematologic Changes in Pregnancy

Full access? Get Clinical Tree
Get Clinical Tree app for offline access